Lisa Ricciardi - 10 Jun 2022 Form 4/A - Amendment Insider Report for COGNITION THERAPEUTICS INC (CGTX)

Role
CEO & President, Director
Signature
/s/ James M. O'Brien, Attorney-in-Fact
Issuer symbol
CGTX
Transactions as of
10 Jun 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
23 Jun 2022, 16:06:09 UTC
Date Of Original Report
13 Jun 2022
Previous filing
14 Oct 2021
Next filing
16 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGTX Stock Option (Right to Buy) Award $0 +150,000 $0.000000 150,000 10 Jun 2022 Common Stock 150,000 $1.92 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amendment is being filed solely for the purpose of correcting a scrivener's error in this item. The correct exercise price is "$1.92" as shown herein, and not "$1.98" as was inadvertently entered in the original filing.
F2 The option vests 25% on June 10, 2023, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service through the applicable vesting dates.